These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4160610)

  • 21. Density gradient centrifugations of adenovirus-antibody comlexes.
    Kjellén L
    Arch Gesamte Virusforsch; 1965; 17(3):398-408. PubMed ID: 4160608
    [No Abstract]   [Full Text] [Related]  

  • 22. A STUDY OF THE STORAGE STABILITY OF VIRAL ANTISERA.
    NAGLER FP; POLLEY JR
    Can J Microbiol; 1965 Jun; 11():503-7. PubMed ID: 14346126
    [No Abstract]   [Full Text] [Related]  

  • 23. ANTIBODY FORMATION IN VITRO BY SEPARATED SPLEEN CELLS: INHIBITION BY ACTINOMYCIN OR CHLORAMPHENICOL.
    SVEHAG SE
    Science; 1964 Oct; 146(3644):659-61. PubMed ID: 14191707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations on the interactions between poliovirus RNA and the host cell under the influence of some salt solutions.
    Morfei A; Popa L; Burducea O; Portocală R
    Acta Virol; 1969 May; 13(3):169-78. PubMed ID: 4389104
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients.
    Clarke JK; Dane DS; Dick GW
    Brain; 1965 Dec; 88(5):953-62. PubMed ID: 4159846
    [No Abstract]   [Full Text] [Related]  

  • 26. Poliomyelitis associated with type-2 poliovirus vaccine strain. Possible transmission from an immunised child to a non-immunised child.
    Stolley PD; Joseph JM; Allen JC; Deane G; Janney JH
    Lancet; 1968 Mar; 1(7544):661-3. PubMed ID: 4170650
    [No Abstract]   [Full Text] [Related]  

  • 27. [RESEARCH ON DISSOCIABILITY BY MEANS OF HEAT OF THE NEUTRALIZING POLIOVIRUS-ANTIBODY COMPLEXES].
    MONTI-BRAGADIN C; MELONI GA; CARLEVARO C
    Riv Ist Sieroter Ital; 1965; 40():18-26. PubMed ID: 14305078
    [No Abstract]   [Full Text] [Related]  

  • 28. Neutralization of poliovirus by IgA coproantibodies.
    Keller R; Dwyer JE
    J Immunol; 1968 Aug; 101(2):192-202. PubMed ID: 4174493
    [No Abstract]   [Full Text] [Related]  

  • 29. The gamma globulin content of meconium and amniotic fluid and the intestinal immunity of the newborn to poliovirus.
    Rosen FS; Lepow ML; Robbins FC
    Arch Gesamte Virusforsch; 1967; 22(1):263-72. PubMed ID: 4176824
    [No Abstract]   [Full Text] [Related]  

  • 30. CHARACTERIZATION OF ANTIBODIES PRODUCED BY GUINEA PIGS INOCULATED WITH INACTIVATED FOOT-AND-MOUTH DISEASE ANTIGEN.
    GRAVES JH; COWAN KM; TRAUTMAN R
    J Immunol; 1964 Apr; 92():501-6. PubMed ID: 14139019
    [No Abstract]   [Full Text] [Related]  

  • 31. The immune response to vaccination with inactivated poliovirus vaccine in Sweden.
    Böttiger M; Arro L; Lundbeck H; Salenstedt CR
    Acta Pathol Microbiol Scand; 1966; 66(2):239-56. PubMed ID: 4163071
    [No Abstract]   [Full Text] [Related]  

  • 32. [COMPARATIVE ATTEMPTS TO DEMONSTRATE ANTIBODIES AGAINST POLIOMYELITIS VIRUS WITH THE NEUTRALIZATION TEST AND THE IMMUNOFLUORESCENCE METHOD].
    BOSELLA F
    Boll Ist Sieroter Milan; 1964; 43():249-52. PubMed ID: 14199041
    [No Abstract]   [Full Text] [Related]  

  • 33. Bovine enteric cytopathogenic viruses. II. Neutralization studies with human sera.
    Rovozzo GC; Luginbuhl RE
    Cornell Vet; 1965 Oct; 55(4):567-75. PubMed ID: 4159413
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of immune serum globulin during storage: effects of modifications in the fractionation scheme.
    Painter RH; Minta JO
    Vox Sang; 1969 Nov; 17(5):434-44. PubMed ID: 4188200
    [No Abstract]   [Full Text] [Related]  

  • 35. The secretion of virus-neutralizing antibodie.
    Giovanardi A; Albano A; Amante L; De Donato S; Pernis B
    Arch Gesamte Virusforsch; 1967; 21(2):178-91. PubMed ID: 4173574
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibodies to echovirus type 30 in the Canadian population.
    Duncan IB
    Can Med Assoc J; 1968 Oct; 99(16):786-90. PubMed ID: 4176074
    [No Abstract]   [Full Text] [Related]  

  • 37. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEASLES-NEUTRALIZING AND HI ANTIBODY TITERS OF HUMAN GAMMA GLOBULIN PREPARATIONS.
    MILLIAN SJ; SCHAEFFER M
    Public Health Rep (1896); 1965 Jan; 80(1):65-7. PubMed ID: 14255454
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.